United States · Series B startup

Who invested in Orna Therapeutics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Valuation: $1.5B, Mar 2026

Funding summaryUpdated 15 Nov 2026

$221Mraised across 1 round since 2022, from 1 source

Latest round
Series B, $221MAug 2022
Investors
0
See who backed them

The rounds

  1. Aug 2022
    Series B$221M

    No investor was named in the report.

    Source recordedSEC filing: $121M sold, first sale Aug 2022

Quick answers about Orna Therapeutics

How much has Orna Therapeutics raised?

Orna Therapeutics has raised $221M across 1 round since 2022.

When did Orna Therapeutics last raise?

Orna Therapeutics's most recent round was a Series B of $221M in Aug 2022.

What was Orna Therapeutics's biggest round?

Its most recent round, $221M in Aug 2022, is also its largest on record.

What stage is Orna Therapeutics at?

Orna Therapeutics's latest named round is a Series B, in Aug 2022.

Where is Orna Therapeutics based?

Orna Therapeutics is based in the United States.

Companies like Orna Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.